Chromocell Therapeutics (CHRO) Stock Chart & Stock Price History → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free CHRO Stock Alerts $2.30 +0.13 (+5.99%) (As of 10:09 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsSocial Media Chromocell Therapeutics Stock Price Performance5 Day Performance+25.68%1 Month Performance+17.95% Receive CHRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. CHRO Stock Chart for Wednesday, May, 15, 2024 CHRO Chart by TradingView Chromocell Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$2.53$2.17-14.23%$2.59$1.9121,584 shs$12.76 million05/13/2024$1.83$2.53+38.25%$2.76$1.88121,129 shs$14.88 million05/10/2024$1.77$1.83+3.39%$1.90$1.822,105 shs$10.76 million05/09/2024$1.75$1.77+1.14%$1.83$1.77940 shs$10.41 million05/08/2024$1.79$1.75-2.23%$1.92$1.672,331 shs$10.29 million05/07/2024$1.66$1.79+7.83%$1.85$1.666,825 shs$10.53 million Get the Latest News and Ratings for CHRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$1.77$1.66-6.22%$1.81$1.6611,222 shs$9.76 million05/03/2024$1.74$1.77+1.73%$1.93$1.7015,299 shs$10.41 million05/02/2024$1.77$1.74-1.69%$1.79$1.664,536 shs$10.23 million05/01/2024$1.79$1.77-1.12%$1.81$1.764,021 shs$10.41 million04/30/2024$1.62$1.79+10.49%$1.79$1.6214,916 shs$10.53 million04/29/2024$1.60$1.62+1.25%$1.73$1.565,215 shs$9.53 million04/26/2024$1.50$1.60+6.67%$1.78$1.4726,702 shs$6.21 million04/25/2024$1.57$1.50-4.46%$1.66$1.499,681 shs$5.82 million04/24/2024$1.56$1.57+0.64%$1.63$1.5010,300 shs$6.09 million04/23/2024$1.40$1.56+11.43%$1.80$1.3116,344 shs$6.05 million04/22/2024$1.54$1.40-9.09%$1.64$1.4026,192 shs$5.43 million04/19/2024$1.23$1.54+25.71%$1.75$1.30119,182 shs$5.98 million04/18/2024$1.99$1.23-38.44%$1.87$1.2126,306 shs$4.75 million04/17/2024$1.82$1.99+9.34%$2.04$1.8311,312 shs$7.72 million04/16/2024$1.95$1.82-6.67%$1.95$1.6123,087 shs$7.06 million04/15/2024$2.00$1.95-2.44%$2.25$1.8937,059 shs$7.57 million04/12/2024$1.83$2.00+9.19%$2.00$1.816,414 shs$7.76 million04/11/2024$1.86$1.83-1.32%$1.94$1.816,007 shs$7.10 million04/10/2024$1.97$1.86-5.84%$1.91$1.838,755 shs$7.20 million04/09/2024$2.15$1.97-8.37%$2.19$1.9028,111 shs$7.64 million04/08/2024$2.29$2.15-6.11%$2.33$2.0319,003 shs$8.33 million04/05/2024$2.34$2.29-2.14%$2.58$2.2921,798 shs$8.89 million04/04/2024$2.59$2.34-9.65%$2.45$2.3312,249 shs$9.07 million04/03/2024$2.40$2.59+7.92%$2.59$2.3314,139 shs$10.05 million04/02/2024$2.39$2.40+0.42%$2.50$2.3329,246 shs$9.31 million04/01/2024$2.62$2.39-8.78%$2.66$2.3927,018 shs$9.27 million03/29/2024$2.62$2.62$2.74$2.5531,842 shs$10.16 million03/28/2024$2.71$2.62-3.32%$2.74$2.5531,847 shs$10.17 million03/27/2024$2.44$2.71+11.07%$2.75$2.40163,598 shs$10.52 million03/26/2024$2.50$2.44-2.40%$2.62$2.3721,645 shs$9.47 million03/25/2024$2.46$2.50+1.63%$2.70$2.3235,956 shs$9.70 million03/22/2024$2.78$2.46-11.51%$2.82$2.4665,557 shs$9.55 million03/21/2024$2.87$2.78-3.14%$2.99$2.6536,989 shs$10.79 million03/20/2024$3.04$2.87-5.59%$3.05$2.7517,324 shs$11.14 millionTrump’s Former Wingman Bets Big on AI (Ad)One of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here.03/19/2024$3.13$3.04-2.88%$3.14$2.6333,939 shs$11.78 million03/18/2024$3.31$3.13-5.44%$3.33$3.0316,193 shs$12.14 million03/15/2024$3.38$3.31-2.07%$3.50$3.1624,690 shs$12.84 million03/14/2024$3.58$3.38-5.59%$3.65$3.3811,594 shs$13.10 million03/13/2024$3.45$3.58+3.77%$3.68$3.5016,607 shs$13.89 million03/12/2024$3.32$3.45+3.92%$3.65$3.3123,656 shs$13.39 million03/11/2024$3.54$3.32-6.21%$3.63$3.2923,375 shs$12.88 million03/08/2024$3.62$3.54-2.21%$3.61$3.2515,138 shs$13.74 million03/07/2024$3.38$3.62+7.10%$3.65$3.4013,835 shs$14.05 million03/06/2024$3.27$3.38+3.36%$3.55$3.2812,710 shs$13.11 million03/05/2024$3.27$3.270.00%$3.55$3.2619,120 shs$12.68 million03/04/2024$3.65$3.27-10.41%$3.82$3.1634,629 shs$12.69 million03/01/2024$3.77$3.65-3.18%$3.84$3.6513,308 shs$14.16 million02/29/2024$3.75$3.77+0.53%$3.94$3.768,377 shs$14.63 million02/28/2024$4.00$3.75-6.25%$4.26$3.7516,868 shs$14.55 million02/27/2024$4.20$4.00-4.76%$4.36$4.0030,117 shs$15.52 million02/26/2024$4.33$4.20-3.00%$4.74$4.0272,388 shs$16.30 million02/23/2024$4.80$4.33-9.79%$4.74$4.335,737 shs$0.0002/22/2024$4.78$4.80+0.42%$4.80$4.504,916 shs$0.0002/21/2024$4.80$4.78-0.42%$4.84$4.3410,524 shs$0.0002/20/2024$4.80$4.80$4.80$3.7025,437 shs$0.0002/19/2024N/A$4.80$6.00$4.54357,100 shs$0.00 Related Companies: Genetic Technologies Stock Chart BioCardia Stock Chart Organovo Stock Chart Inhibikase Therapeutics Stock Chart Sorrento Therapeutics Stock Chart Coeptis Therapeutics Stock Chart Titan Pharmaceuticals Stock Chart Palisade Bio Stock Chart Creative Medical Technology Stock Chart Fresh Tracks Therapeutics Stock Chart Receive CHRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CHRO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldBiden to Drop BOMBSHELL June 13th?Paradigm PressForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chromocell Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.